ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 265 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $620,381 | -46.2% | 35,169 | -31.4% | 0.16% | +5.2% |
| Q1 2022 | $1,154,000 | +460.2% | 51,243 | +358.5% | 0.15% | +316.2% |
| Q4 2021 | $206,000 | -57.1% | 11,177 | -68.9% | 0.04% | -19.6% |
| Q3 2021 | $480,000 | -18.2% | 35,900 | +13.2% | 0.05% | -43.9% |
| Q2 2021 | $587,000 | +70.6% | 31,718 | +33.3% | 0.08% | +3.8% |
| Q1 2021 | $344,000 | 0.0% | 23,800 | 0.0% | 0.08% | +1.3% |
| Q4 2020 | $344,000 | -65.1% | 23,800 | -65.6% | 0.08% | +30.0% |
| Q3 2018 | $986,000 | -45.5% | 69,191 | -45.6% | 0.06% | -72.9% |
| Q3 2017 | $1,810,000 | +1674.5% | 127,200 | +1551.9% | 0.22% | +414.0% |
| Q1 2016 | $102,000 | +24.4% | 7,700 | +16.7% | 0.04% | -39.4% |
| Q3 2015 | $82,000 | -56.4% | 6,600 | -55.1% | 0.07% | -77.3% |
| Q4 2014 | $188,000 | -99.9% | 14,700 | +52.2% | 0.31% | +216.2% |
| Q3 2014 | $129,589,000 | +51529.1% | 9,660 | -30.5% | 0.10% | -54.4% |
| Q1 2014 | $251,000 | – | 13,900 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |